News
Ozempic, Weight Loss and food and drug administration
Digest more
Semaglutide is associated with a high prevalence of adverse events, and its long-term safety is unknown. In an observational ...
Many people using GLP-1 weight-loss drugs like Ozempic, Wegovy or Mounjaro regain the weight after stopping-experts explain ...
A former head of the US Food and Drug Administration cut his body fat in half using GLP-1 drugs. In his book, he compares the ...
In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro ...
The side effects of the two drugs combined include dizziness, abnormal sensations, altered taste, insomnia, constipation and ...
New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...
A new study suggests that weight-loss drugs may significantly reduce alcohol consumption in people with obesity.
A game-changing medication known for diabetes and weight loss might also hold the key to improving liver health for millions of Americans.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results